Recent Updates
Recently added Catalysts
KPTI Positive Sentiment Score: 70/100

Karyopharm to Participate at Upcoming Investor Conferences

Key Takeaway: Karyopharm Therapeutics Inc. (Nasdaq: KPTI) will have its senior management participate in two upcoming investor conferences in September. The conferences include the H.C. Wainwright 26th Annual Global Investment Conference and the Baird 2024 Global Healthcare Conference. These events will feature a podium presentation and a fireside chat, respectively. Investors can access live webcasts and accompanying slides through the company's Investor section on their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in prestigious investor conferences enhances visibility.
  • Management team engagement shows confidence in company's prospects.
  • Live webcasts provide transparency and accessibility to investors.

Full Press Release Details

NEWTON, Mass., Sept. 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the following investor conferences in September:
H.C. Wainwright 26th Annual Global Investment Conference
Format: Podium presentation
Date: Tuesday, September 10, 2024
Baird 2024 Global Healthcare Conference
Format: Fireside chat
Date: Wednesday, September 11, 2024
A live webcast of these events, along with accompanying slides, can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay following the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
SOURCE Karyopharm Therapeutics Inc.

21 %

more press release views with

Frequently Asked Questions

What conferences will Karyopharm participate in September 2024?

Karyopharm will participate in the H.C. Wainwright and Baird conferences.

What date is the H.C. Wainwright conference?

The H.C. Wainwright conference is on September 10, 2024.

How can I access the conference webcasts?

Webcasts and slides will be available in the Investor section of Karyopharm's website.

What is Karyopharm known for?

Karyopharm develops innovative cancer therapies, including XPOVIO® and NEXPOVIO®.

When is the Baird Global Healthcare Conference?

The Baird conference will take place on September 11, 2024.

Last updated: Sep 3, 2024